Negative cooperativity in H2 relaxin binding to a dimeric relaxin family peptide receptor 1

Molecular and Cellular Endocrinology
Angela Manegold SvendsenJane Nøhr

Abstract

H2 relaxin, a member of the insulin superfamily, binds to the G-protein-coupled receptor RXFP1 (relaxin family peptide 1), a receptor that belongs to the leucine-rich repeat (LRR)-containing subgroup (LGRs) of class A GPCRs. We recently demonstrated negative cooperativity in INSL3 binding to RXFP2 and showed that this subgroup of GPCRs functions as constitutive dimers. In this work, we investigated whether the binding of H2 relaxin to RXFP1 also shows negative cooperativity, and whether this receptor functions as a dimer using BRET(2). Both binding and dissociation were temperature dependent, and the pH optimum for binding was pH 7.0. Our results showed that RXFP1 is a constitutive dimer with negative cooperativity in ligand binding, that dimerization occurs through the 7TM domain, and that the ectodomain has a stabilizing effect on this interaction. Dimerization and negative cooperativity appear to be general properties of LGRs involved in reproduction as well as other GPCRs.

References

Jan 1, 1976·Journal of Supramolecular Structure·P De Meyts
Jun 16, 1975·Biochemical and Biophysical Research Communications·L E LimbirdR J Lefkowitz
Nov 1, 1973·Biochemical and Biophysical Research Communications·P de MeytsM A Lesniak
Jul 3, 1999·Nature Genetics·S Nef, L F Parada
Mar 22, 2000·Proceedings of the National Academy of Sciences of the United States of America·S AngersM Bouvier
Jan 26, 2002·Science·Sheau Yu HsuAaron J W Hsueh
Feb 23, 2002·The Journal of Biological Chemistry·ChangWoo LeeTae H Ji
Aug 24, 2002·Biology of Reproduction·Richard Ivell, Ross A D Bathgate
Oct 3, 2002·Nature Reviews. Drug Discovery·Pierre De Meyts, Jonathan Whittaker
Mar 29, 2003·The Journal of Biological Chemistry·Yan LiangAndreas Engel
Jan 8, 2004·EMBO Reports·Sonia Terrillon, Michel Bouvier
Apr 15, 2004·Endocrine Reviews·O David Sherwood
May 13, 2004·Expert Review of Molecular Diagnostics·Anders Heding
Jun 12, 2004·Journal of Biomolecular Screening·Milka VreclAnders Heding
Jan 15, 2005·The Journal of Pharmacology and Experimental Therapeutics·Michelle L HallsRoger J Summers
Jan 22, 2005·Nature·Qing R Fan, Wayne A Hendrickson
Feb 15, 2005·BMC Evolutionary Biology·Tracey N WilkinsonRoss A D Bathgate
Apr 23, 2005·Endocrinology·B M C McGowanS R Bloom
Jun 16, 2005·Annals of the New York Academy of Sciences·Michelle L HallsRoger J Summers
Jun 16, 2005·Annals of the New York Academy of Sciences·Ross A BathgateRoger J Summers
Jun 16, 2005·Annals of the New York Academy of Sciences·Gillian D Bryant-GreenwoodLynnae K Millar
Jun 16, 2005·Annals of the New York Academy of Sciences·Richard IvellRavinder Anand-Ivell
Jun 16, 2005·Annals of the New York Academy of Sciences·Tracey N WilkinsonRoss A D Bathgate
Jun 28, 2005·Cytokine & Growth Factor Reviews·Jean-Yves SpringaelMarc Parmentier
Jul 22, 2005·Endocrine·William R MoyleMichael P Bernard
Mar 21, 2006·The Journal of Biological Chemistry·Mark P Del BorgoJohn D Wade
Mar 30, 2006·Molecular Pharmacology·Michelle L HallsRoger J Summers
May 2, 2006·Pharmacology & Therapeutics·Thomas DschietzigKarl Stangl
Nov 23, 2006·Journal of Receptor and Signal Transduction Research·Milka VreclAnders Heding
Feb 3, 2007·Current Drug Targets·E T Van Der WesthuizenP M Sexton
Jul 12, 2007·Reproductive Biology and Endocrinology : RB&E·Marcelo FilonziMaria F M Lazari
Jul 28, 2007·Pharmacology & Therapeutics·Jean-Yves SpringaelMarc Parmentier
Sep 8, 2007·Thyroid : Official Journal of the American Thyroid Association·Basil Rapoport, Sandra M McLachlan

❮ Previous
Next ❯

Citations

Dec 23, 2008·Heart Failure Reviews·Sam L TeichmanGad Cotter
Sep 1, 2011·The Journal of Biological Chemistry·Mohammed Akhter HossainJohn D Wade
Nov 17, 2010·Pharmacological Reviews·Nicola J Smith, Graeme Milligan
Jun 18, 2014·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Thomas Bernd Dschietzig
Jan 17, 2014·Kidney International·Bryna S Man ChowChrishan S Samuel
Feb 9, 2010·Molecular and Cellular Endocrinology·Roy C K KongRoss A D Bathgate
May 29, 2015·Cell and Tissue Research·Ali Mohammed PitiaTetsuya Kohsaka
May 7, 2009·Annals of the New York Academy of Sciences·Angela Manegold SvendsenJane Nøhr
May 7, 2009·Annals of the New York Academy of Sciences·Brigham J HartleyRoss A D Bathgate
Mar 22, 2016·Trends in Pharmacological Sciences·Chrishan S SamuelTim D Hewitson
Nov 26, 2009·Nature Reviews. Cardiology·Xiao-Jun DuRoger J Summers
Jan 24, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Xiaohan SongNan Wang
Feb 27, 2020·Molecular Genetics & Genomic Medicine·Ting-Yun ChenYingze Zhang
Jan 11, 2013·Physiological Reviews·R A D BathgateR J Summers
Aug 7, 2019·Pharmacology Research & Perspectives·Bradley L HoareRoss A D Bathgate
Dec 31, 2014·ACS Chemical Biology·Linda M Haugaard-KedströmK Johan Rosengren
Jan 15, 2011·Biochemistry·Mohammed Akhter HossainChrishan S Samuel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis